NewEdge Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$128K Sell
5,255
-129
-2% -$3.14K ﹤0.01% 2341
2025
Q1
$112K Buy
5,384
+1,780
+49% +$37K ﹤0.01% 2263
2024
Q4
$84.9K Sell
3,604
-2,716
-43% -$64K ﹤0.01% 2330
2024
Q3
$162K Sell
6,320
-1,368
-18% -$35K ﹤0.01% 2049
2024
Q2
$181K Sell
7,688
-12,381
-62% -$291K ﹤0.01% 1953
2024
Q1
$577K Sell
20,069
-1,952
-9% -$56.1K 0.01% 1258
2023
Q4
$722K Sell
22,021
-8,181
-27% -$268K 0.01% 1101
2023
Q3
$841K Sell
30,202
-6,631
-18% -$185K 0.01% 937
2023
Q2
$1.26M Sell
36,833
-16,834
-31% -$574K 0.01% 763
2023
Q1
$1.6M Sell
53,667
-3,932
-7% -$118K 0.02% 599
2022
Q4
$883K Buy
57,599
+15,752
+38% +$242K 0.02% 551
2022
Q3
$1.38M Buy
41,847
+3,110
+8% +$102K 0.02% 537
2022
Q2
$1.22M Sell
38,737
-894
-2% -$28.1K 0.02% 596
2022
Q1
$1.82M Sell
39,631
-3,422
-8% -$157K 0.03% 448
2021
Q4
$2.64M Buy
43,053
+19,717
+84% +$1.21M 0.04% 374
2021
Q3
$1.74M Buy
23,336
+1,443
+7% +$108K 0.04% 352
2021
Q2
$2.03M Buy
21,893
+7,921
+57% +$733K 0.05% 313
2021
Q1
$1.24M Buy
13,972
+987
+8% +$87.6K 0.04% 393
2020
Q4
$1.21M Buy
12,985
+4,312
+50% +$402K 0.04% 373
2020
Q3
$553K Buy
8,673
+4,342
+100% +$277K 0.02% 544
2020
Q2
$226K Buy
+4,331
New +$226K 0.01% 743
2019
Q3
Sell
-7,743
Closed -$267K 816
2019
Q2
$267K Buy
7,743
+278
+4% +$9.59K 0.02% 550
2019
Q1
$245K Buy
+7,465
New +$245K 0.02% 581
2018
Q4
Sell
-8,044
Closed -$269K 628
2018
Q3
$269K Buy
+8,044
New +$269K 0.02% 523